EXPERIMENTAL CANNABINOID-LIKE DERIVATIVE KILLS PATIENT IN FRANCE

http://www.independent.co.uk/news/world/europe/france-clinical-trial-one-person-brain-dead-and-five-more-in-hospital-after-drug-testing-a6813791.html

We’ve all noticed the recent news headline shown above from a clinical trial in France. First, let me be clear. The molecule that killed one patient and left several others in a coma, is a non-cannabis based molecule that acts on the Endocannabinoid System.

This new group of drugs that are molecular “pieces” of cannabinoid molecules are developed to activate or suppress a cannabinoid receptor.

You might ask, why use pieces or “ligands” of molecules when we have the whole plant version already growing everywhere? Plants are tough to patent and make into medications; ligands or little pieces of molecules can be patented and turned into pharmaceuticals.

This is not the first time this has happened. There is a drug called rimonabant, which blocks the CB-1 receptor, was used nine years ago as an appetite suppressant. The idea being, CB-1 receptor activation gives us the “munchies” so if we block the receptor, appetite should be repressed. Well, it was, but the side effect was severe depression and a number of suicides. This was in theory predictable and a handful of cannabis physicians sent warnings regarding it’s release.

The Endocannabinoid system is complex and connects virtually every cell in our body. It is incredibly complex and we are still in the very early stage of understanding, despite our knowing about the ECS since 1990.

This all makes me very sad. People are dying from cannabis based molecular “bath salts”.

I am certain that science and pharmaceutical companies will in fact develop many great cannabinoid based molecules that treat patients in ways that the plant perhaps cannot. At the same time, this is a reminder that we have a very, very safe complex and multi-molecular medicine – Whole Plant Cannabis medicine grown in the ground.

Author
Allan Frankel, MD Dr Allan Frankel is one of the few physicians in the US who truly understands Cannabis as a medicine. All treatments suggested have been well studied. Every patient seen by Dr Frankel is given a personally created Treatment Plan created with the patient's specific issues defined. Plant medicine requires "tuning" of the dosing. Dr Frankel works with his patients thru a messaging portal. The use of this portal, allows quick and simple follow up contact with Dr Frankel. Patients are not charged for these messages, as this is how Dr Frankel has learned what he has learned. Follow up appointments in person or by phone/video are also available when needed

You Might Also Enjoy...

WHILE CONSIDERING CHEMOTHERAPY…

Dr Frankel talks about chemotherapy, it's issues/side effects, and how cannabis can alleviate some of those issues, prevent others, and help enhance the effectiveness of the chemo. He uses a few patient cases to illustrate his approach.

DR MERCOLA INTERVIEWS DR ALLAN FRANKEL

Dr. Mercola interviews Dr. Frankel on many areas of medical cannabis. Topics discussed range from THCV, home growing, dabbing issues, Cannabis Hyperemesis, Myasthenia Gravis and the future of medical cannabis.

EPIDIOLEX VERSUS WHOLE PLANT CANNABIS CBD

Dr Frankel has long been a proponent of using whole plant, cannabis derived CBD products and a recent case in which a patient had less effective results when switching to a prescribed CBD isolate further cemented his stance on what works best for patients

CAN CANNABIS CAUSE ARTERIAL DAMAGE?

Dr Frankel gives his thoughts and counterpoints on the potential issue of cannabis causing arterial damage after some articles were recently circulating about this subject.

POTENTIAL BENEFITS OF THC-V

Dr Frankel talks about his experience using THC-V for different medical issues, the initial results he has seen and his hope for more research to be done.